SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001072613-17-000381
Filing Date
2017-07-11
Accepted
2017-07-11 14:02:16
Documents
1
Group Members
ANTHONY A. FLORENCE, JR.DAVID M. MOTTFOREST BASKETTM. JAMES BARRETTNEA 14 GP, LTDNEA PARTNERS 14, L.P.PATRICK J. KERINSPETER J. BARRISPETER W. SONSINIRAVI VISWANATHANSCOTT D. SANDELL

Document Format Files

Seq Description Document Type Size
1 MERSANA THERAPEUTICS, INC. - SCHEDULE 13D mersana13d_18088.htm SC 13D 389622
  Complete submission text file 0001072613-17-000381.txt   391578
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Subject) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90033 | Film No.: 17959630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093
Business Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 410-842-4000
New Enterprise Associates 14, L.P. (Filed by) CIK: 0001544328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D